Safety of ultra-low contrast coronary angiography in patients with acute kidney injury

Clin Cardiol. 2024 May;47(5):e24282. doi: 10.1002/clc.24282.

Abstract

Background: Ultra-low contrast administration during coronary angiography has been previously shown to be feasible and safe among patients with stable chronic kidney disease. In the present study, we investigate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury (AKI).

Methods: The study was a retrospective single-center evaluation of hospitalized patients who had AKI and required coronary angiography. Ultra-low contrast use was defined as ≤18 mL of contrast media.

Results: The cohort consisted of a case series of eight inpatients with AKI who required coronary angiography. The mean age was 57 (±16) years and half were females. All patients had chronic kidney disease with a mean baseline estimated glomerular filtration rate of 34 (±17) mL/min/1.73 m2. The mean creatinine before angiography was 3 (±1) mg/dL and volume of contrast administered was 14 (±4) mL. One patient had a 0.1 mg/dL increase in creatinine during admission, and no patients had further AKI up to 1-week postprocedure.

Conclusions: The current data suggest that ultra-low contrast coronary angiography can be safely performed in patients with pre-existing AKI The study should be viewed as hypothesis-generating due to its small sample size. A larger cohort is required to validate the results.

Keywords: AKI; acute renal failure; contrast‐induced nephropathy; coronary angiography; ultra‐low contrast.

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Adult
  • Aged
  • Contrast Media* / administration & dosage
  • Contrast Media* / adverse effects
  • Coronary Angiography* / methods
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnosis
  • Creatinine / blood
  • Female
  • Glomerular Filtration Rate*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors

Substances

  • Contrast Media
  • Creatinine